Search Filters

Search Results

Found 3 results

510(k) Data Aggregation

    K Number
    K994323
    Date Cleared
    2000-03-08

    (77 days)

    Product Code
    Regulation Number
    880.5440
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    KAWASUMI LABORATORIES CO., LTD.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A CONDUIT FOR BLOOD REMOVAL FROM A PATIENT TO A VACUUM BOTTLE TO AID IN THE TREATMENT OF A DISEASE OR OTHER CONDITION.

    Device Description

    A STERILE, SINGLE USE DEVICE FOR WITHDRAWING BLOOD. BASIC CONCEPT: A CONDUIT USED FOR WITHDRAWING BLOOD FROM THE PATIENT'S VEIN TO A VACUUM BOTTLE RESERVOIR

    AI/ML Overview

    This document describes a 510(k) submission for a medical device (Kawasumi Laboratories Phlebotomy Set) and, as such, focuses on demonstrating substantial equivalence to a predicate device rather than comprehensive performance studies with detailed acceptance criteria typically found in AI/ML device submissions.

    Therefore, many of the requested elements (e.g., sample sizes for test sets, number of experts, adjudication methods, MRMC studies, standalone performance, training set details) are not applicable or available in this type of regulatory submission. The device is a relatively simple, sterile, single-use blood collection set, and the focus is on its basic function and safety.

    Here's a breakdown of the available information based on your request:


    1. Table of Acceptance Criteria and the Reported Device Performance

    Acceptance CriteriaReported Device Performance
    Biocompatibility: Device materials contacting body fluids must be suitable for intended use.Kawasumi Laboratories conducted biocompatibility tests on body fluid-contacting material portions. The data is believed to show the device is suitable for its intended use. (Implied acceptance: No adverse biocompatibility reactions or material toxicity.)
    Pyrogenicity: Device must be non-pyrogenic.The device meets all pyrogenicity test requirements. (Implied acceptance: Absence of fever-inducing substances.)
    Performance: Device effectively removes blood from a patient into a vacuum bottle, performing as well as the predicate device.The device's basic concept is "A conduit used for withdrawing blood from the patient's vein to a vacuum bottle reservoir." The submission states, "There are no significant performance characteristics of this device compared to substantially equivalent devices marketed for sale... The device is used to remove blood from a patient into a vacuum bottle." Conclusion: The device "performs as well as the predicate device."
    Safety: Device is as safe as the predicate device.Conclusion: "Therefore, it is as safe as the predicate device and performs as well as the predicate device."

    2. Sample size used for the test set and the data provenance

    • Not applicable/Available. This submission focuses on demonstrating substantial equivalence through design and material characteristics, along with standard biocompatibility and pyrogenicity testing, rather than a clinical "test set" in the context of AI/ML or diagnostic performance.
    • Data Provenance: Not specified, but standard regulatory tests (biocompatibility, pyrogenicity) are typically performed in certified laboratories.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • Not applicable/Available. There is no "ground truth" establishment in the sense of expert review of data for a diagnostic or AI/ML algorithm. Safety and performance are assessed via specified tests and comparison to a predicate.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    • Not applicable/Available. No such adjudication method is mentioned or relevant for this type of device submission.

    5. If a multi-reader, multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • No. This is a basic medical device (phlebotomy set), not an AI-assisted diagnostic tool.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • No. This is a basic medical device, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    • Not applicable. The "ground truth" for this device's performance and safety is based on validated laboratory testing methods (e.g., ISO standards for biocompatibility and pyrogenicity) and the established performance of the predicate device.

    8. The sample size for the training set

    • Not applicable/Available. There is no "training set" in the context of an AI/ML algorithm.

    9. How the ground truth for the training set was established

    • Not applicable/Available. No training set exists for this device.
    Ask a Question

    Ask a specific question about this device

    K Number
    K974829
    Date Cleared
    1998-02-12

    (50 days)

    Product Code
    Regulation Number
    880.5965
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    KAWASUMI LABORATORIES CO., LTD.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    INFUSION OF FLUIDS, INCLUDING THOSE CONTAINING MEDICATIONS, FROM A CONTAINER TO A PORT IMPLANTED IN, OR OTHERWISE ATTACHED TO, A PATIENT TO AID IN THE DIAGNOSIS OR TREATMENT OF DISEASE OR OTHER CONDITIONS.

    Device Description

    A NON-PVC PORT ACCESS INFUSION SET IS A STERILE, SINGLE USE DEVICE WITH A NEEDLE, WING, NON-PVC I.D. TUBING AND NON-PVC COMPONENTS USED FOR ACCESSING IMPLANTED MEDICATION PORTS.

    AI/ML Overview

    Here's an analysis of the provided text regarding the acceptance criteria and study for the device K974829:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance CriteriaReported Device Performance
    Biocompatibility requirementsDevice meets all biocompatibility test requirements.
    Pyrogenicity requirementsDevice meets all pyrogenicity test requirements.
    Limulus Amebocyte Lysate ("LAL") Test (USP XXII)Device meets the LAL test described at "(85) Bacterial Endotoxins Test", USP XXII, pp 1493-1495.

    2. Sample Size Used for the Test Set and Data Provenance

    The provided text does not contain information regarding the sample size used for the test set or the data provenance (e.g., country of origin, retrospective or prospective). The document only mentions that Kawasumi Laboratories "conducted biocompatibility tests on the body fluid contacting material portions of the device."

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    The provided text does not contain information regarding the number of experts used to establish ground truth or their qualifications. The studies mentioned are laboratory tests (biocompatibility, LAL) and do not appear to involve expert-driven ground truth establishment in a clinical context.

    4. Adjudication Method for the Test Set

    The provided text does not contain information regarding an adjudication method. The tests described are objective laboratory tests.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size

    No, an MRMC comparative effectiveness study was not conducted. The document focuses on demonstrating substantial equivalence to a predicate device based on material characteristics and basic safety tests, not on improving human reader performance.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study Was Done

    The device is an "Infusion Set," which is a physical medical device, not an algorithm or AI system. Therefore, a standalone algorithm study is not applicable and was not performed.

    7. The Type of Ground Truth Used

    The ground truth for the device's performance was established through objective laboratory tests, specifically:

    • Biocompatibility tests: These typically involve in-vitro and sometimes in-vivo toxicology assessments against established ISO standards or similar guidelines.
    • Pyrogenicity testing: This refers to the LAL test, which is a standardized method to detect bacterial endotoxins.

    8. The Sample Size for the Training Set

    The provided text does not contain information regarding a training set sample size. As the device is not an AI/ML algorithm, the concept of a "training set" is not applicable in this context.

    9. How the Ground Truth for the Training Set Was Established

    As the device is not an AI/ML algorithm, the concept of a "training set" and establishing ground truth for it is not applicable. The "ground truth" for the device's safety and performance was established through the aforementioned laboratory tests on the device materials.

    Ask a Question

    Ask a specific question about this device

    K Number
    K964117
    Date Cleared
    1997-03-14

    (150 days)

    Product Code
    Regulation Number
    880.5965
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    KAWASUMI LABORATORIES CO., LTD.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    ROUTINELY USED TO ACCESS IMPLANTED MEDICATION PORTS FOR THE DELIVERY OF MEDICATIONS.

    Device Description

    A NON-PVC PORT ACCESS INFUSION SET IS A STERILE, SINGLE USE DEVICE WITH A NEEDLE, WING, NON-PVC I.D. TUBING AND NON-PVC COMPONENTS USED FOR ACCESSING IMPLANTED MEDICATION PORTS.

    AI/ML Overview

    The provided text does not contain information about acceptance criteria and a study proving a device meets them in the context of AI/ML performance evaluation. The document describes a medical device (KAWASUMI LABORATORIES NON-PVC FLUID PATH PORT ACCESS INFUSION SET WITH SLIT SEPTUM INJECTION SITE) and its performance data relates to biocompatibility and pyrogenicity tests, not AI/ML model performance.

    Therefore, I cannot populate the table or answer the questions related to AI/ML study design, sample sizes, expert ground truth, or adjudication methods based on the provided text.

    The only relevant information that can be extracted is about the performance data for the described medical device:

    Acceptance Criteria and Device Performance (Biocompatibility/Pyrogenicity)

    Acceptance CriteriaReported Device Performance
    Biocompatibility Tests (on body fluid contacting material portions)Device is suitable for its intended use.
    Limulus Amebocyte Lysate ("LAL") Test (described at "(85) BACTERIAL ENDOTOXINS TEST", USP XXII, PP 1493-1495)The device meets the LAL test.

    The text explicitly states: "The device meets all biocompatibility and pyrogenicity test requirements."

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1